LivaNova Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BYMT0J19
USD
63.90
0.22 (0.35%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Globus Medical, Inc.
Glaukos Corp.
Sanmina Corp.
ICU Medical, Inc.
Neogen Corp.
Merit Medical Systems, Inc.
LivaNova Plc
Axonics, Inc.
CONMED Corp.
Integra LifeSciences Holdings Corp.
Inari Medical, Inc.
Why is LivaNova Plc ?
1
Poor Management Efficiency with a low ROE of 4.32%
  • The company has been able to generate a Return on Equity (avg) of 4.32% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate -217.51% of over the last 5 years
3
Positive results in Jun 25
  • OPERATING CASH FLOW(Y) Highest at USD 216.59 MM
  • DEBT-EQUITY RATIO (HY) Lowest at -9.87 %
  • CASH AND EQV(HY) Highest at USD 1,332.08 MM
4
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 22.34%, its profits have fallen by -277.1%
5
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Market Beating Performance
  • The stock has generated a return of 22.34% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to LivaNova Plc should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is LivaNova Plc for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
LivaNova Plc
23.79%
0.43
45.98%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
5.95%
EBIT Growth (5y)
-217.51%
EBIT to Interest (avg)
0.57
Debt to EBITDA (avg)
0.74
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.66
Tax Ratio
15.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
4.88%
ROE (avg)
4.32%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.45
EV to EBIT
-13.31
EV to EBITDA
-18.71
EV to Capital Employed
2.60
EV to Sales
1.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.55%
ROE (Latest)
-25.56%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 216.59 MM

DEBT-EQUITY RATIO (HY)

Lowest at -9.87 %

CASH AND EQV(HY)

Highest at USD 1,332.08 MM

NET SALES(Q)

Highest at USD 352.52 MM

OPERATING PROFIT(Q)

Highest at USD 67.47 MM

OPERATING PROFIT MARGIN(Q)

Highest at 19.14 %

-10What is not working for the Company
NET PROFIT(HY)

At USD -318.69 MM has Grown at -977.87%

ROCE(HY)

Lowest at -17.87%

Here's what is working for LivaNova Plc
Operating Cash Flow
Highest at USD 216.59 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at -9.87 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Net Sales
Highest at USD 352.52 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 67.47 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 19.14 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Cash and Eqv
Highest at USD 1,332.08 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Depreciation
Highest at USD 15.04 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for LivaNova Plc
Net Profit
At USD -318.69 MM has Grown at -977.87%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)